Recce Pharmaceuticals

Recce Pharmaceuticals EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Recce Pharmaceuticals (RCE.AX) as of Oct 9, 2026 is -22.29 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -22.52 M AUD — a change of -1.04% (higher).

EBITDA

-22.29 MAUD

YoY

-1.04%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Recce Pharmaceuticals is 2026 -22.29 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Recce Pharmaceuticals was 2025 -22.52 M AUD. It decreases by -1.04% higher compared to the previous year.

The Recce Pharmaceuticals EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-3.36 M AUD
Jan 1, 2020
-5.21 M AUD
Jan 1, 2021
-15.07 M AUD
Jan 1, 2022
-13.96 M AUD
Jan 1, 2023
-16.99 M AUD
Jan 1, 2024
-21.35 M AUD
Jan 1, 2025
-22.52 M AUD
Jan 1, 2026
-22.29 M AUD
The Recce Pharmaceuticals EBITDA history
YEAREBITDAYoY
-22.29 MAUD-1.04%
-22.52 MAUD+5.48%
-21.35 MAUD+25.70%
-16.99 MAUD+21.67%
-13.96 MAUD-7.34%
-15.07 MAUD+189.40%
-5.21 MAUD+54.83%
-3.36 MAUD+17.78%
-2.86 MAUD-9.61%
-3.16 MAUD-34.25%
-4.80 MAUD+992.92%
-439,615.00AUD+67.67%
-262,188.00AUD—
Access this data via the Eulerpool API
Get Free API Key

Recce Pharmaceuticals Stock analysis

What does Recce Pharmaceuticals do? Recce Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Recce Pharmaceuticals stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Recce Pharmaceuticals is -22.29 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Recce Pharmaceuticals changed from -22.52 M AUD to -22.29 M AUD, representing a -1.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Recce Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Recce Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Recce Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Recce Pharmaceuticals